Top

Published in:

01-11-2004 | Breast

The relationship between vascular and metabolic characteristics of primary breast tumours

Authors: Scott I. K. Semple, Fiona J. Gilbert, Thomas W. Redpath, Roger T. Staff, Trevor S. Ahearn, Andrew E. Welch, Steven D. Heys, Andrew W. Hutcheon, Elizabeth H. Smyth, Shailesh Chaturvedi

Published in: European Radiology | Issue 11/2004

Abstract

The objective of this study was to investigate the relationship between vascular and metabolic characteristics of breast tumours in vivo, using contrast-enhanced dynamic MRI and 2-[¹⁸F] fluoro-2-deoxy-d-glucose (FDG) PET imaging. Twenty patients with large or locally advanced primary breast cancers were imaged prior to therapy. MRI data were acquired using a dynamic gradient echo sequence and analysed using two pharmacokinetic models. Static PET data were acquired in 2D mode. A significant association (P<0.05) was observed between the calculated exchange rate constants of both pharmacokinetic models and calculated PET FDG dose uptake ratios (DUR). Statistical analysis showed that the exchange rate constants can explain between 27 and 44% of the variance observed in the PET FDG uptake ratios. A relationship was demonstrated between the vascular and metabolic characteristics of primary breast tumours showing that any assessment of tumour metabolic activity using PET may be controlled at least in part by delivery of uptake agent due to the vascular characteristics of the tumour. MRI and PET provide methods of assessing breast tumour vascularity and metabolism in vivo using the exchange rate constants of dynamic MRI, and DUR of PET, respectively, these measures being related but not equivalent.

Semple SIK, Gilbert FJ, Redpath TW, Ahearn TS, Welch AE, Hutcheon AW, Heys SD, Smyth EH, Miller ID, Smith IC (2003) Correlation of MRI-PET rim enhancement in breast cancer. A delivery related phenomenon with therapy implications? Lancet Oncol 4:759CrossRefPubMed

Heywang SH (1994) Contrast enhanced magnetic resonance imaging of the breast. Invest Radiol 29:94–104PubMed

Flickinger FW, Allison JD, Sherry RM, Wright JC (1993) Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast-enhanced MRI. J Magn Reson Imaging 11:617–620CrossRef

Tsuboi N, Inomata T, Ogawa Y, Yoshida D, Yoshida S, Moriki T, Kumon M (1999) Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: pathologic correlation. Oncol Rep 6:727–732PubMed

Kuhl CK (2000) MRI of breast tumors. Eur Radiol 10:46–58CrossRefPubMed

Hayes C, Padhani AR, Leach MO (2002) Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 15:154–163PubMed

Rieber A, Brambs H-J, Gabelmann A, Heilmann V, Keinberg R, Kühn T (2002) Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 12:1711–1719CrossRefPubMed

Tofts PS, Berkowitz B, Schnall MD (1995) Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. J Magn Reson Med 33:564–568

Hoffman U, Brix G, Knopp MV, Heß T, Lorenz WJ (1995) Pharmacokinetic mapping of the breast: a new method for dynamic mammography. J Magn Reson Med 33:506–514

10.

Bombardieri E, Crippa F, Maffioli L, Greco M (1997) Nuclear medicine techniques for the study of breast cancer. Eur J Nucl Med 24:809–824CrossRefPubMed

11.

Flanagan FL, Dehdashti F, Siegel BA (1998) PET in breast cancer. Semin Nucl Med 28:290–302PubMed

12.

Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R (1993) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 11:2101–2111PubMed

13.

Bassa P, Kim EE, Inoue T, Wong FCL, Korkmaz M, Yang DJ, Wong WH, Hicks KW, Buzdar AU, Podoloff DA (1996) Evaluation of preoperative chemotherapy using PET with fluorine-18-flourodeoxyglucose in breast cancer. J Nucl Med 37:931–938PubMed

14.

Smith IC, Welch AE, Hutcheon AW, Miller ID, Payne S, Chilcott F, Waikar S, Whitaker T, Ah-See AK, Eremin O, Heys SD, Gilbert FJ, Sharp PF (2000) Positron emission tomography using [¹⁸F]-fluorodeoxy-d-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 18:1676–1688PubMed

15.

Brix G, Henze M, Knopp MV, Lucht R, Doll J, Junkermann H, Hawighorst H, Haberkorn U (2001) Comparison of pharmacokinetic MRI and [¹⁸F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience. Eur Radiol 11:2058–2070CrossRefPubMed

16.

Wienhard K, Eriksson K, Grootoonk S, Casey M, Pietrzyk U, Heiss WD (1992) Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 16:804–813PubMed

17.

Semple SIK, Redpath TW, Ahearn TS, Gilbert FJ, Hutcheon AW, Heys SD (2003) Effect of accurate T1 calculation on pharmacokinetic analysis of primary breast cancer. In: Proceedings of the 11th annual meeting of ISMRM, Toronto, Canada

18.

Tofts PS, Kermode AG (1991) Measurement of the blood–brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. J Magn Res Med 17:357–367

19.

Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15:621–628PubMed

20.

Knopp MV, Brix G, Junkermann HJ, Sinn HP (1994) MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 2:633–658PubMed

21.

Tofts PS, Brix G, Buckley DL, Eveloch JL, Henderson E, Knopp M, Larsson HBW, Lee T-Y, Mayr NA, Parker GJM, Port RE, Taylor J, Weisskoff RM (1999) Estimating kinetic parameters from dynamic contrast-enhanced T₁-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed

22.

Ahearn TS (2003) The accuracy and robustness of dynamic contrast enhanced magnetic resonance imaging methodology. Ph.D Thesis, University of Aberdeen, pp 159–174

23.

Hathaway PB, Mankoff DA, Maravilla KR, Austin-Seymour MM, Ellis GK, Gralow JR, Cortese AA, Hayes CE, Moe RE (1999) Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience. Radiology 210:807–814PubMed

24.

Goerres GW, Michel SCA, Fehr MK, Kaim AH, Steinert HC, Seifert B, von Schulthess GK, Kubik-Huch RA (2003) Follow-up of women with breast cancer: comparison between MRI and FDG PET. Eur Radiol 13:1635–1644CrossRefPubMed

25.

Kim CK, Gupta NC, Chanramouli B, Alavi A (1994) Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med 35:164–167PubMed

26.

Weinmann HJ, Laniado M, Mutzel W (1984) Pharmacokinetics of Gd-DTPA/Dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16:167–172PubMed

27.

Williams KV, Bertoldo A, Mattioni B, Price JC, Cobelli C, Kelley DE (2003) Glucose transport and phosphorylation in skeletal muscle in obesity: insight into a muscle-specific positron emission tomography model. J Clin Endocrinol Metab 88:1271–1279CrossRefPubMed

28.

Zasadny KR, Tatsumi M, Wahl RL (2003) FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers. Eur J Nucl Med Mol Imaging 30:274–280PubMed

29.

Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Charlop A, Lawton TJ, Schubert EK, Tseng J, Livingston RB (2002) Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 43:500–509PubMed

30.

Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Schubert EK, Tseng J, Lawton TJ, Linden HM, Livingston RB (2003) Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 44:1806–1814PubMed

Title: The relationship between vascular and metabolic characteristics of primary breast tumours
Authors: Scott I. K. Semple
Fiona J. Gilbert
Thomas W. Redpath
Roger T. Staff
Trevor S. Ahearn
Andrew E. Welch
Steven D. Heys
Andrew W. Hutcheon
Elizabeth H. Smyth
Shailesh Chaturvedi
Publication date: 01-11-2004
Publisher: Springer-Verlag
Published in: European Radiology / Issue 11/2004
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-004-2454-6

At a glance: The STEP trials

Springer Medicine

The relationship between vascular and metabolic characteristics of primary breast tumours

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2004

Calcific myonecrosis: a report of ten new cases with an emphasis on MR imaging

Magnetic resonance image registration and subtraction in the assessment of minor changes in low grade glioma volume

Dobutamine stress MRI. Part II. Risk stratification with dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia

Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer

MR imaging in neuroborreliosis of the cervical spinal cord

Diffusion-weighted MR imaging in acute spinal cord ischemia